Loading…
L-asparaginase-induced severe necrotizing pancreatitis successfully treated with percutaneous drainage
L‐asparaginase is a key component of the antileukemic therapy in children with acute lymphoblastic leukemia (ALL). Pancreatitis has been noted to be a complication in 2–16% of patients undergoing treatment with L‐asparaginase for a variety of pediatric neoplasms. Most cases of pancreatitis associate...
Saved in:
Published in: | Pediatric Blood & Cancer 2005-01, Vol.44 (1), p.95-97 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | L‐asparaginase is a key component of the antileukemic therapy in children with acute lymphoblastic leukemia (ALL). Pancreatitis has been noted to be a complication in 2–16% of patients undergoing treatment with L‐asparaginase for a variety of pediatric neoplasms. Most cases of pancreatitis associated with L‐asparaginase toxicity are self‐limiting and respond favorably to nasogastric decompression and intravenous hyperalimentation. However, in rare instances, hemorrhagic pancreatitis or necrosis may occur. L‐asparaginase‐induced pancreatitis is an uncommon but potential lethal complication of the treatment of leukemia. We present a pediatric patient with leukemia and a severe, L‐asparaginase‐induced necrotizing pancreatitis, treated successfully with percutaneous drainage used to flush the infected necrotic parts. © 2004 Wiley‐Liss, Inc. |
---|---|
ISSN: | 1545-5009 1545-5017 1096-911X |
DOI: | 10.1002/pbc.20187 |